A new type of cell-based immunotherapy shows promise for B-cell lymphomas, and due to innovations in manufacturing, could ...

A new type of off-the-shelf cell-based immunotherapy shows promise for B-cell lymphomas, and could make make future cellular ...

A phase 1 clinical trial co-led by researchers at Washington University School of Medicine in St. Louis found that a new type ...

A new type of cell-based immunotherapy shows promise for B-cell lymphomas and — due to innovations in manufacturing — could make future cellular ...

Thanks to an innovative method of super-resolution microscopy, researchers observed with molecular resolution in 3D how therapeutic antibodies attack and alter B cells, thereby inducing their ...

Researchers have developed a new microscopic method to observe the interactions of therapeutic antibodies with target molecules on tumor cells.

Würzburg researchers show how therapeutic antibodies work – thanks to an innovative method of super-resolution microscopy.

Professor Michel Sadelain, of Canadian origins, was announced the 2025 laureate for King Faisal Prize in Medicine for his groundbreaking contributions to Chimeric Antigen Receptor (CAR) T-cell therapy ...

Sanofi NCT01421667 A study of brentuximab vedotin in relapsed or refractory non-Hodgkin lymphoma Seattle Genetics, Inc. NCT01786135 A safety study of SGN-CD19A for B-cell lymphoma Seattle Genetics ...

Meanwhile, the Phase 2 EPCORE® NHL-1 trial evaluating epcoritamab monotherapy in relapsed or refractory large B-cell lymphoma ...